Obtaining Reliable Linguistic and Cultural Validation of the Questionnaires Cargier Bruden Inventony (CBI) and Zarit-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

264 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-11-22

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To validate the 2 questionnaires ZARIT-12 and CBI it is important to go through several stages:

1. translation stage : during this stage there will be a meeting of experts to Validate the test version in French by 4 Bilingual translators of the French and English mother tongue.
2. pilot stage : recruit a number of 30 neurological patients' caregivers, in order to validate the comprehension, thus obtaining the final version of the questionnaire.
3. Validation stage : the two questionnaires have been validated, in this stage there should be a recruitment of 264 participants for the CBI questionnaire and 120 participants for the ZARIT-12 questionnaire, and these 2 questionnaires will be deliver to the participant on the same day.

* The first questionnary will have to be filled the day they get the questionnary (day 1).
* The second one must be completed and sent fourteen days later (day 14).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To validate the 2 questionnaires ZARIT-12 and CBI it is important to go through several stages:

1. translation stage : during this stage there will be a meeting of experts to Validate the test version in French by 4 Bilingual translators of the French and English mother tongue.
2. pilot stage : recruit a number of 30 neurological patients' caregivers, in order to validate the comprehension, thus obtaining the final version of the questionnaire.
3. Validation stage : the two questionnaires have been validated, in this stage there should be a recruitment of 264 participants for the CBI questionnaire and 120 participants for the ZARIT-12 questionnaire, and these 2 questionnaires will be deliver to the participant on day 1. The first questionnary will have to be filled on day 1 and the second one must be completed and sent fourteen days later (so on day 14)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Physical Medicine and Rehabilitation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Caregivers (family or friend) of patients followed for a central neurological pathology (MS, BM, Parkinson's, stroke, congenital (Spina...)) or peripheral (ponytail, peripheral neuropathies)
* Adult caregivers (age ≥ 18 years), regardless of the patient's age
* Francophone caregivers (ability to read, write and understand French)
* Caregivers who did not object to the use of their data or the patient's data for research

Exclusion Criteria

* \- Professional caregivers
* caregivers of patients being cared for with a pathology other than neurological
* Minor caregivers (age ≤ 17 years)
* Caregivers with no or poor French language skills
* Caregivers who refused to participate in the research

Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital Delafontaine

Saint-Denis, Seine Saint Denis, France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

TURMEL Nicolas

Role: CONTACT

Phone: 0142356140

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CHSD_0027_MPR

Identifier Type: -

Identifier Source: org_study_id